the aid library

Key
Resources
Clinical
Guidelines
Women & Child
Health
Pharmacy &
Technologies
Public
Health
Capacity
Building
COUNTRIES
TOOLBOXES
- Conflict
- Zika
- TB
- Cholera
- HIV
- Polio
- Rapid Response
- Refugee
- Disability
- Specific Hazards
- Social Ethics
- Health Financing Toolbox

Middle East and North Africa
West and Central Africa
East and Southern Africa
South–East Asia Region
Western Pacific Region
Eastern Europe and Central Asia
Latin America and the Carribbean
Western and Central Europe
North America

Login
Register
English

Search database

Create your MEDBOX

Filter

Filtered Results: 65

Text search: Rachel Phillipson

Featured

Recommendations

New Publications

Language

English

French

Russian

Portuguese

Spanish

Arabic

Thai

Document type

No document type

Guidelines

Manuals

Studies & Reports

Countries / Regions

Brazil

Global

Guinea-Bissau

Ghana

Nepal

Mozambique

Ukraine

Angola

Lesotho

Africa

Eastern Europe

Russia

Authors & Publishers

World Health Organization WHO

World Health Organization

et al.

World Health Organization (WHO)

UNAIDS

UNICEF

H. Ingold

Journal of the International AIDS Society

Organisation mondiale de la Santé

Organisation Mondiale de la Santé (OMS)

UNISDR

Unitaid (Innovation in Global Health)

USAID

World Health Organisation (WHO)

Всемирная организация здравоохранения

A. Abdul-Quader

A. Abdul-Quader, M. Berry, T. Bingham

A. Armstrong

ALNAP

Alzheimer's Disease International

B. M. McCoy

Bertozzi, Stefano

Bloom, Barry R.

C. Pérez Casas

Centers for Diseases Control and Prevention

Cohen, R., Sharonann, L., Bygrave, H., et al

Current Tropical Medicines Report

E. Corbett

Erin Berry-Bibee, Melissa Chen, Kathryn Curtis et al.

European Centre for Disease Prevention and Control (ECDC)

F. Terris-Prestholt

fhi360

Francesca Bonino and Ian Christoplos

GNP+ (Global Network of people living with HIV)

Hesperian Foundation

HIV Self-Testing Africa Initiative

Holmes, King K.

International Bank for Reconstruction and Development/ The World Bank

J. Burnett

J. Bushee

J. M. Nagata

J. W. Eaton

J.Hows

Jha, Prabhat

John Beard, Alana Officer, Andrew Cassels et al.

Journal of Acquired Immune Deficiency Syndromes (JAIDS )

Journal of the International AIDS Society (JIAS)

K. Suzuki, R. E. Simmonds et al.

Karin Hatzold

M. Berry

M. Vicari

MCHIP

Ministry of Health, Ghana

MSMGF

National Academies of Sciences, Engineering, and Medicine

National Academy of Medicine

Nepal Health Sector Support Programme

O. Ajose

OPAS

Organisation mondial de la Santé

Organização Mundial da Saúde (OMS)

Ovid

Prince, M., and J. Jackson

PubMed.gov

R. C. Vreeman

R. Gustav

Rachel Phillipson

S. Lee

T. Bingham

U.S. Department of Health and Human Services.

UNDP

UNITAID

United Nations Children's Fund (UNICEF) & World Health Organisation (WHO)

United Nations Office on Drugs and Crime

V. Cambiano

Vikram Patel, Dan Chisholm, Tarun Dua et al.

Wakefield, M.K.

WHO, THE END TB STRATEGY

World Bank

Yotsu,R.R.

Всемирная организация здравоохранения (ВОЗ)

Всемирная организация здравоохранения (Европа)

Publication Years

2000-2009

2010-2019

2020-2025

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19. Orientação Provisória. 2 de março de 2021
recommended

World Health Organization WHO (2021) C_WHO

Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...19 e receberam hidroxicloroquina. Três estudos envolveram participantes que tiveram uma exposição conhecida a uma pessoa com infecção por SARS-CoV-2. Em resposta à divulgação dos dados de estudos, o GDG da OMS desenvolveu recomendações sobre a hidroxicloroquina, um agente anti-inflamatório que atua por meio do bloqueio dos receptores Toll-like, reduzindo a ativação das células dendríticas. É usada para tratar a artrite reumatoide e o lúpus eritematoso sistêmico. Tem um efeito antiviral contra muitos vírus in vitro, inclusive o SARS-CoV-2, mas não foi demonstrado um efeito antiviral clinicamente útil para nenhuma infecção viral. more

Download

View PDF

Add to my MEDBOX

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19 : 2 DE MARÇO DE 2021

Organização Mundial da Saúde (OMS) OPAS (2021) C_WHO

Resumo: o que é esta orientação dinâmica? Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19? Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde. Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...variável, refletindo uma incerteza em grande escala. Numerosos estudos clínicos randomizados de muitos medicamentos estão em andamento para orientar melhor a prática. Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS contém novas informações e uma recomendação sobre a hidroxicloroquina. (1) Segue-se a publicação de seis estudos sintetizados em uma meta-análise dinâmica de rede (NMA). more

External Link

Add to my MEDBOX

Future of Nursing 2020-2030

Wakefield, M.K.; et al. National Academy of Medicine; National Academies of Sciences, Engineering, and Medicine (2021) C1

Charting a Path to Achieve Health Equity. The decade ahead will test the nation's nearly 4 million nurses in new and complex ways. Nurses live and work at the intersection of health, education, and communities. Nurses work in a wide array of settings and practice at a range of professional levels. T...hey are often the first and most frequent line of contact with people of all backgrounds and experiences seeking care and they represent the largest of the health care professions. Free download available, register for free more

Download

View PDF

Add to my MEDBOX

Drugs to prevent COVID-19: living guideline

World Health Organisation (WHO) (2023) C_WHO

The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform. Guidelines ...regarding the use of drugs to treat (rather than prevent) COVID-19 are included in a separate WHO document, Therapeutics and COVID-19: living guideline, that can via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform). Guidelines regarding the clinical management of COVID-19 patients are included in a further document, COVID-19 Clinical management: Living guideline, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform). more

Download

View PDF

Add to my MEDBOX

Guidelines for drinking-water quality: Small water supplies

World Health Organization WHO (2024) C_WHO

Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs and opportunities associated with these supplies therefore warrant explicit consideration in policies and regulati...ons. These Guidelines, specifically tailored to small water supplies, build on over 60 years of guidance by the World Health Organization (WHO) on drinking-water quality and safety. They focus on establishing drinking-water quality regulations and standards that are health based and context appropriate; on proactively managing risks through water safety planning and sanitary inspections; and on carrying out independent surveillance. The guidance is intended primarily for decision-makers at national and subnational levels with responsibility for developing regulatory frameworks and support programmes related to these activities. Other stakeholders involved in water service provision will also benefit from the guidance in this document. Designed to be practical and accessible, these Guidelines offer clear guidance that is rooted in the principle of progressive improvement. State-of-the-art recommendations and implementation guidance are provided, drawn from a comprehensive evidence review and established good practices. Additionally, case examples are provided from countries and areas around the world to demonstrate how the guidance in this publication has been implemented in practice in a wide variety of contexts. Together with WHO’s 2024 Sanitary inspection packages – a supporting tool for the Guidelines for drinking-water quality: small water supplies, these Guidelines update and supersede WHO’s 1997 Guidelines for drinking-water quality. Volume 3: surveillance and control of community supplies. Key changes to this updated publication include a greater focus on preventive risk management and a broader range of small water supplies covered, including those managed by households, communities and professional entities. more

Create your own MEDBOX
Login

Home
Contact
Data privacy
Legal notice
FAQ
About
Sitemap

A Project by

dev-medbox @ 2025

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19. Orientação Provisória. 2 de março de 2021 recommended

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19 : 2 DE MARÇO DE 2021

Future of Nursing 2020-2030

Drugs to prevent COVID-19: living guideline

Guidelines for drinking-water quality: Small water supplies

Orientação dinâmica da OMS: Medicamentos para prevenção da COVID-19. Orientação Provisória. 2 de março de 2021
recommended